Reply to N. Biran et al

J Clin Oncol. 2020 Apr 20;38(12):1368-1369. doi: 10.1200/JCO.20.00042. Epub 2020 Mar 11.

Authors

Sagar Lonial¹, Madhav V Dhodapkar¹, S Vincent Rajkumar¹

Affiliation

¹ Sagar Lonial, MD, Madhav V. Dhodapkar, MBBS, MD, Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA; and S. Vincent Rajkumar, MD, Division of Hematology, Mayo Clinic, Rochester, MN.

PMID: 32160076
DOI: 10.1200/JCO.20.00042

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Lenalidomide
Smoldering Multiple Myeloma*

Substances

Lenalidomide